Related Experiment Video
Updated: Feb 9, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives
1Cardiovascular Department, Azienda Sanitaria Universitaria Integrata, University of Trieste (ASUITS), Trieste, Italy.
Insights
Dilated cardiomyopathy (DCM) treatment now improves outcomes through reverse remodeling. This review details reverse remodeling in DCM and offers clinical management guidance.
Area of Science:
- Cardiology
- Heart Failure Research
- Medical Science
Background:
- Dilated cardiomyopathy (DCM) was historically a progressive disease leading to heart failure.
- Prognosis has improved due to successful therapy-induced reverse remodeling.
Purpose of the Study:
- To review current understanding of reverse remodeling in DCM.
- To provide clinical management recommendations for DCM patients.
Main Methods:
- Literature review on reverse remodeling in DCM.
- Analysis of therapeutic effectiveness and prognostic implications.
- Discussion of predictors and genetic interactions.
Main Results:
- Reverse remodeling is a key indicator of therapeutic success in DCM.
- It involves multiple cardiac structures beyond the left ventricle.
- Understanding predictors and timing of quantification is crucial.
Conclusions:
- Reverse remodeling significantly improves DCM prognosis.
- Further research is needed on its predictors and genetic influences.
- Clinical management should incorporate reverse remodeling insights.
Abstract:
Dilated Cardiomyopathy (DCM) has been classically considered a progressive disease of the heart muscle that inexorably progresses towards refractory heart failure, ventricular arrhythmias and heart transplant. However, the prognosis of DCM has significantly improved in the past few years, mostly as the result of successful therapy-induced reverse remodeling. Reverse remodeling is a complex process that involves not only the left ventricle, but also many other cardiac structures and it is now recognized both as a measure of therapeutic effectiveness and as an important prognostic tool. Nevertheless, several aspects of reverse remodeling remain unclear, including the best timing for its quantification, its predictors and its interaction with individual genetic backgrounds. In this review, we summarize our current understanding of reverse remodeling in patients with DCM and provide practical recommendations for the clinical management of this challenging patient population.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
Cardiomyopathy V: Interprofessional Care

